Cargando…

Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma

Detalles Bibliográficos
Autores principales:	Derman, Benjamin A., Jakubowiak, Andrzej J., Thompson, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276661/ https://www.ncbi.nlm.nih.gov/pubmed/35821020 http://dx.doi.org/10.1038/s41408-022-00705-6

Ejemplares similares

Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation
por: Derman, Benjamin A., et al.
Publicado: (2021)

Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma
por: Chiu, Brian C.-H., et al.
Publicado: (2022)

Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis
por: Derman, Benjamin A., et al.
Publicado: (2020)

Oprozomib in patients with newly diagnosed multiple myeloma
por: Hari, Parameswaran, et al.
Publicado: (2019)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Wang, Bei, et al.
Publicado: (2022)

Clinician preferences on treatment of smoldering myeloma: a cross-sectional survey
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2023)

Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot study
por: Derman, Benjamin A, et al.
Publicado: (2020)

Whether to make decisions "on the fly" regarding treatment for SARS-CoV-2 infection()
por: Abril López de Medrano, V., et al.
Publicado: (2020)

Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma
por: Martinez-Lopez, Joaquin, et al.
Publicado: (2021)

Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma
por: Derman, Benjamin A., et al.
Publicado: (2023)

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
por: Nooka, Ajay K., et al.
Publicado: (2022)

Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
por: Ailawadhi, Sikander, et al.
Publicado: (2018)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
por: Chakraborty, Rajshekhar, et al.
Publicado: (2021)

Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry
por: Noori, Somayya, et al.
Publicado: (2023)

Infectious complications of bispecific antibody therapy in patients with multiple myeloma
por: Sim, Beatrice Z., et al.
Publicado: (2023)

Medical decision-making competence regarding puberty suppression: perceptions of transgender adolescents, their parents and clinicians
por: Vrouenraets, Lieke Josephina Jeanne Johanna, et al.
Publicado: (2022)

Survey of UK clinicians’ approaches to decision making in neonatal intestinal failure
por: Cairns, Pamela, et al.
Publicado: (2022)

Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians
por: Banerjee, Rahul, et al.
Publicado: (2023)

Pure red cell aplasia and minimal residual disease conversion associated with immune reconstitution in a patient with high‐risk multiple myeloma
por: Jin, Xianghong, et al.
Publicado: (2023)

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
por: Landgren, Ola, et al.
Publicado: (2019)

Patient Preference and Satisfaction in Decision-Making Process
por: Pae, Chi-Un
Publicado: (2014)

Detection of myeloma cell-derived microvesicles: a tool to monitor multiple myeloma load
por: Liu, Zhao-Yun, et al.
Publicado: (2023)

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
por: Sivaraj, Dharshan, et al.
Publicado: (2018)

Smoldering Multiple Myeloma Arising in Ulcerative Colitis
por: Yang, Xue, et al.
Publicado: (2018)

Impact of mitochondrial DNA mutations in multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2020)

P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA
por: Derman, B., et al.
Publicado: (2022)

Setting Priorities for Optimizing Vascular Access Decision Making – An International Survey of Patients and Clinicians
por: van der Veer, Sabine N., et al.
Publicado: (2015)

Access to Chemical Data Used in Regulatory Decision Making
por: Goldman, Lynn R., et al.
Publicado: (2013)

Making decisions to mitigate COVID-19 with limited knowledge
por: Zhang, Weituo, et al.
Publicado: (2020)

Joint Efforts to Ensure Evidence‐Based Decisions by Clinicians in Drug Adjustment for Chronic Liver Disease Populations
por: Ferreira, Victor, et al.
Publicado: (2021)

Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma
por: Jain, Tania, et al.
Publicado: (2017)

Incorporating clinical guidelines through clinician decision-making
por: Falzer, Paul R, et al.
Publicado: (2008)

A systematic classification of death causes in multiple myeloma
por: Mai, Elias K., et al.
Publicado: (2018)

Characterization of rare germline variants in familial multiple myeloma
por: Catalano, Calogerina, et al.
Publicado: (2021)

Sensitive multiple myeloma disease monitoring by mass spectrometry
por: Santockyte, Rasa, et al.
Publicado: (2021)

The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
por: Tariq, Syed Maaz, et al.
Publicado: (2023)

Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020
por: Van Oekelen, Oliver, et al.
Publicado: (2022)

Preferences and flexibility in decision-making among dental clinicians regarding the treatment of multirooted teeth: an interactive communication device-based survey at two academic conferences
por: Lee, Jung-Seok, et al.
Publicado: (2016)

Decision-making on the labour ward during the COVID-19 pandemic
por: Bruce-Hickman, K., et al.
Publicado: (2021)

An international clinician survey CompAring Nonabsorbable Vs. Absorbable sutures for Skin surgery: the CANVAS study
por: Lee, Alice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_avkt3pfra3tanv350pc70fejn8